Asset Details
Do you wish to reserve the book?
First detection of European bat lyssavirus type 2 (EBLV-2) in Norway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
First detection of European bat lyssavirus type 2 (EBLV-2) in Norway
Do you wish to request the book?
First detection of European bat lyssavirus type 2 (EBLV-2) in Norway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
First detection of European bat lyssavirus type 2 (EBLV-2) in Norway
2017
Overview
Background
In Europe, bat rabies is primarily attributed to
European bat lyssavirus
type 1 (EBLV-1) and
European bat lyssavirus
type 2 (EBLV-2) which are both strongly host-specific. Approximately thirty cases of infection with EBLV-2 in Daubenton’s bats (
Myotis daubentonii
) and pond bats (
M. dasycneme
) have been reported. Two human cases of rabies caused by EBLV-2 have also been confirmed during the last thirty years, while natural spill-over to other non-flying mammals has never been reported. Rabies has never been diagnosed in mainland Norway previously.
Case presentation
In late September 2015, a subadult male Daubenton’s bat was found in a poor condition 800 m above sea level in the southern part of Norway. The bat was brought to the national Bat Care Centre where it eventually displayed signs of neurological disease and died after two days. EBLV-2 was detected in brain tissues by polymerase chain reaction (PCR) followed by sequencing of a part of the nucleoprotein gene, and lyssavirus was isolated in neuroblastoma cells.
Conclusions
The detection of EBLV-2 in a bat in Norway broadens the knowledge on the occurrence of this zoonotic agent. Since Norway is considered free of rabies, adequate information to the general public regarding the possibility of human cases of bat-associated rabies should be given. No extensive surveillance of lyssavirus infections in bats has been conducted in the country, and a passive surveillance network to assess rabies prevalence and bat epidemiology is highly desired.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Bats
/ brain
/ Daubenton’s bat (Myotis daubentonii)
/ European bat lyssavirus type 2 (EBLV-2)
/ fluorescent antibody test (FAT)
/ genes
/ humans
/ Lyssavirus - isolation & purification
/ Male
/ males
/ Medicine
/ Microbiology and Parasitology
/ Myotis
/ Norway
/ polymerase chain reaction (PCR)
/ Polymerase Chain Reaction - veterinary
/ Rabies
/ rabies tissue culture infection test (RTCIT)
/ Rhabdoviridae Infections - epidemiology
/ Rhabdoviridae Infections - veterinary
/ Santé publique et épidémiologie
/ Studies
/ tissues
/ Veterinary Medicine/Veterinary Science
/ Virology
/ Zoology
/ Zoonoses
